Cetimed 10mg Medochemie Medicine Treatment of allergic rhinitis (1 blister x 10 tablets)

Dosage form Film bag tablets
Specifications Box of 1 blister x 10 tablets
Ingredient Cetirizine

Ingredient

Composition informationContent
Cetirizine10mg

Uses

indications

Cetimed drug contains cetirizine dihydrochloride is indicated for adults and children aged 6 and older in the following cases:

  • Reduce symptoms of allergies on nasal and eyes due to seasonal allergic rhinitis and allergic rhinitis all year round. H1 receptor antagonist, Piperazine derivative

    ATC code: R06AE07

    Cetirizine is a metabolite in humans of hydroxyzine; This is a powerful and selective antihistamine on peripheral H1 receptors. Studies on cohesion with in vitro receptors show that Cetirizine has no significant affinity other than receptors H1.

    In addition to the H1 receptor resistance, Cetirizine can also be allergic to 10 mg or twice a day, Cetirizine inhibits the binding of inflammatory cells in the late stage, especially eosinophilia in the skin and conjunctiva in allergens exposed to allergens.

    Clinical and safety effect

    Studies on healthy volunteers show that Cetirizine dihydrochloride at a dose of 5 and 10 mg significantly reduces the edema and rosy reactions due to the very high concentration of histamine in the skin; However, the correlation with the efficiency is not established.

    In a six -week study, with a restraint with a placebo over 186 patients with allergic rhinitis and at the same time, mild to medium asthma, Cetirizine dihydrochloride 10 mg, once a day improved rhinitis symptoms and does not change the coordination function.

    This study supports the safety of the use of Cetirizine dihydrochloride for patients allergies to mild to moderate asthma.

    In a must -and -high -doses of high doses of Cetirizine dihydrochloride, 60 mg in 7 days does not cause significant QT range.

    With daily dose Cetirizine dihydrochloride 10 mg has shown to improve the symptoms of chronic allergic rhinitis and seasonal di rhinitis.

    Pediatric population

    In a 35 -day study of children from 5 to 12 years old, there is no tolerance for antihistamine (anti -edema and rosy) effects of Cetirizine; After using many doses of cetirizine, when the drug is stopped, the symptoms on the skin recover the normal reaction with histamine within 3 days.

    Pharmacokinetics

    absorption

    After drinking, Cetirizine absorbed quickly; The peak concentration of plasma in a stable state is about 0.3 µg/ml and is achieved within about 1 hour after taking the medication.

    The level of Cetirizine absorption is not reduced by food although the absorption speed has decreased.

    Distribution

    Cetirizine is connected to plasma proteins about 93%; However, Cetirizine does not change protein cohesion with warfarin.

    Expression distribution volume is 0.5 l/kg.

    Metabolism

    Cetirizine is less metabolized in the liver.

    Elimination

    About 2/3 of the dose is excreted in the form of unchanged urine.

    There is no cetirizine accumulation after taking a dose of 10 mg once a day in 10 days.

    Selling waste time of plasma is about 10 hours and this time will last in patients with renal failure.

    linear

    Cetirizine has linear pharmacokinetics at the dose from 5 mg to 60 mg.

    pharmacokinetics in special subjects

    Race

    The pharmacokinetic distribution such as the concentration of the medication in plasma and the area under the curve is the same in the healthy, black and white male volunteer.

    Elderly patients

    Research on drug use conducted on 16 elderly people with daily doses of 10 mg once a day recorded a 50% increase in waste time and 40% decreased clearance compared to healthy adults; The decreased clearance in the elderly may be related to the impaired renal function.

    Children

    Cetirizine's waste sale time is about 6 hours in children from 6 to 12 years old and 5 hours in children 2 to 6 years old; In infants and children from 6 months to 24 months, the sale time is only 3.1 hours.

    Patients with renal failure

    There is no difference in pharmacokinetics in patients with mild kidney failure compared to you volunteering for normal kidney function.

    In patients with average renal impairment, tripled waste time and 70% decreased clearance compared to you volunteering for normal kidney function; Therefore, it is necessary to adjust the dose suitable for patients with renal impairment average to severe. Cetirizine is poorly eliminated by hemons.

    Do not prescribe drugs for patients with severe end -stage renal impairment or appointment of hemolysis.

    Patients with liver failure

    Patients with chronic liver failure (such as liver cell disease, bile stasis and cirrhosis due to cholestasis), at a dose of 10 mg or 20 mg once a day, the half -life increased by 50% and the clearance decreased by 40% compared to healthy people; Therefore, it is necessary to consider adjusting the dose in patients with liver failure.

    Preceptic safety data

    Prelise clinical data shows that there are no special dangers in people based on common studies on safety pharmacological pharmacology, repetitive dose toxicity, gene poisoning, cancer, reproductive toxicity.

    Prelopisologically -clinical results are only observed at exposure levels that are considered to exceed the maximum exposure level of humans, which shows little related to clinical use.

  • Before taking Cetimed 10mg Medochemie Medicine Treatment of allergic rhinitis (1 blister x 10 tablets)

    How to use

    Cetimed 10mg drug is indicated for oral, should take medicine with a sufficient amount of water.

    Dosage

    adults

    recommended dose is 10 mg (1 cetimed 10mg tablet) 1 time.

    Elderly patients

    Use as recommended by adults; Except, elderly patients impaired renal function should adjust the dose.

    Patients with renal failure

    There is no effect of evaluating the effectiveness and safety of the use of drugs for patients with renal impairment. Because Cetirizine dihydrochloride is mainly eliminated through the kidneys, in case it cannot be replaced with another drug, the dose and the distance between the doses must be adjusted for each disease depends on the kidney function. In this case, the dosage of the drug should be determined according to the serum creatinine clearance (ml/min) of the patient and calculated according to the following formula:

    Men

    Creatinie clearance (mg/minute) = [(140 - age by year) x Weight (kg)]/[72 x Serum creatine concentration (mg/dl)]

    Women

    Creatinie clearance (mg/minute) = [(140 - Age by year) x Weight (kg)]/[72 x Serum creatine concentration (mg/dl)] x 0.85

    Dosage for kidney failure adjusted according to the following table:

    kidney function Dosage Lightweight 50 - 79 ml/minute 10 mg orally once a day The time end -stage renal failure, patients are separating less than 10 ml/minute

    No dose adjustment in patients with hepatic failure; Except, patients with liver failure accompanied by renal failure should adjust the dose (see the dose information for patients with renal impairment).

    Children

    Children 12 years and older: Use as recommended by adults.

    Children from 6 to 12 years: Take 5 mg (half cetimed 10mg) 2 times.

    Children under 6 years of age: It is not recommended to use Cetimed 10mg for children under 6 years old because they cannot be appropriate.

    Children with renal failure: The dose is adjusted for each patient based on the patient's kidney function, age and weight.

    Note: The above dose is for reference only. Specific dosage depends on the condition and level of progression of the disease. For a suitable dose, you need to consult a doctor or medical specialist.

    What to do when overdose?

    Overdose

    Symptoms recorded after overdose of Cetirizine dihydrochloride overdose are mainly related to unwanted effects on the central nervous system or cholinergic resistance.

    Unwanted effects recorded after taking 1 dose 5 times the recommended daily dose (50 mg) such as confusion, diarrhea, fatigue, headache, discomfort, pupils, itching, restlessness, sedation, sleeping, stunned heart, fast heartbeat, tremor and urinary retention.

    How to handle

    There is no specific detoxification measure when overdose of Cetirizine dihydrochloride overdose; If an overdose occurs, the patient should stop the drug and immediately notify the doctor for appropriate treatment. When an overdose of the drug occurs, patients should be treated with symptoms and support. Can consider gastric lavage if the new dosage occurs.

    The method of separation is not effective to remove the Cetirizine dihydrochloride from the body.

    In an emergency, call the 115 emergency center immediately or go to the nearest local health station.

    What to do when forgetting 1 dose? However, if the time to relax with the next dose is too short, skip the dose and continue the calendar of the drug. Do not use double dose to compensate for missed dose.

    Side Effects

    Clinical studies show that Ceririzine dihydrochloride at the recommended dose can cause some unwanted effects on the central nervous system, including drowsiness, fatigue, dizziness and headache; In some cases, there have been reports on the backward stimulation of the central nervous system. Although, Cetirizine dihydrochloride is a selective antagonist H, peripheral and almost no anti -cholinergic effect, but in some individual cases, difficult urine, eye regulation disorders, dry mouth have been reported.

    Clinical trial

    Control, double clinical trials between Ceritizine dihydrochloride (10 mg/day) with placebo or with other antihistamine drugs, among them are data on safety including more than 3200 subjects for Ceritizine dihydrochloride.

    From these data, in tests with Ceritizine dihydrochloride 10 mg with placebo, unwanted effects are recorded at 1% or more.

    unwanted effects (WHO-ANT) Cetirizine Hydrochloride 10mg (3260 people) 3061)
  • Fatigue
  • 1.63%
  • 0.95%
  • Dizziness
  • headache
  • 1.10%
  • 7.42%
  • 0.98%
  • 8.07%
  • Chemistry:
  • Abdominal pain
  • Mausoleum
  • Sad Vomiting
  • 0.98%
  • 2.09%
  • 1.07%
  • 1.08%
  • 0.82%
  • 1.14%
  • Mental:
  • Sleep
  • 9.63%
  • 5.00%
  • Sore throat
  • 1.29%
  • 1.34%
  • Only less or average sleepiness, objective tests have been shown with other studies showing that the daily dosage (10 mg) does not affect daily activities in healthy volunteers.

    Unwanted effects have a rate not less than 1% of children from 6 to 12 years of age in clinical trials that are controlled with placebo are shown as follows:

    unwanted effect (WHO-ANT) Cetirizine Hydrochloride 10mg (1656 children) diarrhea
  • 1.0%
  • 0.6%
  • Sleeping trade
  • 1.8%
  • 1.4%
  • Rhinitis
  • 1.4%
  • 1.1%
  • Fatigue
  • 1.0%
  • 0.3%
  • The frequency of unexplicated mopng (ADR) is as follows: Very common (ADR ≥1/10), common (1/100 ≤ ADR Blood disorders and lymphatic systems

  • Very rare: platelets.
  • Nutrition and metabolic disorders

  • Unknown: weight gain.
  • Mental disorders

  • Less: agitated.
  • Inexplicable: rare
  • : Convulsions, movement disorders
  • very rare: difficulty reading, fainting, tremor, tongel disorders and movement disorders.
  • Very rare: regulatory disorders, blurring, longan disorders.
  • Unknown: Dizziness.
  • Vascular disorders

  • Rare: Fast stamping heart.
  • Uncommon: diarrhea
  • Rare: Liver function abnormalities such as Transaminases increasing, alkaline phosphates, y-GT and bilirubin.
  • Unknown: Hepatitis.
  • Uncommon: itching, rash; These symptoms will go away on their own after the drug. and will go away on its own after stopping the drug.
  • Unknown: joint pain
  • Very rare: urination, bedwetting
  • Unknown: Urinary retention.
  • Uncommon: weakness, discomfort/hardships.
  • Rare: edema.
  • Rare: weight gain.
  • immune system disorders

  • Rare: Hypersensitivity.
  • Very rare: Anaphylaxis.
  • Warnings

    Before using the drug you need to read the instructions carefully and refer to the information below.

    contraindicated

    Cetimed drugs contraindicated in the following cases:

  • Patients with a history of hypersensitivity to Cetirizine dihydrochloride, with hydroxyzine, with any derivative of piperazine and with any excipients of the drug.

    Caution when used

    in the treatment dose proved that there was no clinical interaction with alcohol (for blood concentration in blood is 0.5 g/1); However, patients should be cautious to use drugs simultaneously with food and alcoholic beverages.

    Patients with liver failure with kidney failure should consult a physician before use; If necessary, the dose for this object can be redefined.

    Be cautious when using drugs for epilepsy patients or patients at risk of convulsions.

    Cetirizine dihydrochloride may increase the risk of urinary retention, so patients with factors affecting urinary retention due to spinal damage or prostate enlargement need to be cautious when taking the drug.

    Itching and/or jute may occur after the drug stops; Even if those symptoms do not appear before the beginning of treatment; In some cases, these symptoms may become serious and repeat treatment requirements; These symptoms will end when they start treatment with Cetirizine dihydrochloride.

    Antihistamine anti -hypersensitivity drugs inhibit skin allergies; Therefore, before performing these tests, patients should stop the drug 3 days in advance for the central nervous system to return to normal state.

    The form of Cetimed 10mg film -making tablets does not allow the appropriate dose adjustment for children under 6 years old; Therefore, it is not recommended to use Cetimed 10mg for children under 6 years old.

    excipients

    In the composition of lactose-containing drug formula, patients with rare genetic diseases in galactose, decreased lactose or reduced absorption of glucose-galactose should not be taken.

    In the formula of the drug containing propylene glycol 0.25 mg in each tablet (200 mg) is equivalent to 0.25mg/200mg.

    Use drugs for women during pregnancy and lactation

    Pregnant women

    Animal research does not see directly or indirectly harmful to pregnancy, the development of embryos, fetus, during and after birth; However, clinical data is limited in the use of Cetirizine Hydrochloride in humans, so pregnant women should not take the drug and use only drugs when really necessary.

    breastfeeding women

    Cetirizine Hydrochloride is excreted in breast milk with a concentration of 25% to 90% of the measured concentration in plasma depending on the sampling time after taking the drug; Breastfeeding women should not take the drug and only take the drug when really necessary.

    The effect of the drug on driving and operating machinery

    Research on healthy volunteers with a dose of 20 to 25 mg/kg/day without any clinical manifestations affecting the ability to drive and operate machinery; However, patients should not overdose recommended and should consider the ability to respond to the drug. In the process of using drugs, patients need kidneys to drive or operate machinery because of unwanted effects on the central nervous system that can occur such as drowsiness, dizziness and headache affecting these activities.

    Drug interaction

    There is no significant interaction between Cetirizine dihydrochloride and other drugs recorded in pharmacokinetic and pharmacokinetic studies.

    In fact, there is no evidence that pharmacokinetic interaction when using cetirizine and other drugs such as pseudoepherine, theophyllline (at a dose of 400 mg/ day). In theoophyllline multi -dose study (every 400 mg dose once a day) and Cetirizine dihydrochloride has seen a slight decrease (16%) of the clearance of Cetirizine Hydrochloride; Meanwhile, the webyline's distribution level is not affected when used simultaneously with Cetirizine dihydrochloride.

    The absorbing food of Cetirizine Dihydrochloride although the absorption rate decreases by 1 hour.

    For patients with sensitivity, simultaneous use of Cetirizine dihydrochloride with food and alcoholic beverages or other central neurological inhibitors will increase the impact on the nervous system that is impaired alertness and active ability.

    Mutual medicine

    Due to the lack of studies on the cavalry of the drug, Cetimed 10mg is not mixed with other drugs.

  • Storage

    Leave a cool place, avoid light, temperature below 30⁰C.

    To be out of reach of children.

    Other drugs

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    count views

    Popular Keywords